Assistant Professor, Surgery, Case Western Reserve University School of Medicine
General Surgery
Dr. Federico N. Aucejo, MD
|
|
Give Review
Federico Aucejo is an expert in the field of General Surgery. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Federico Aucejo is a published doctor. He has 49 publications published. The most current publication "Sonic hedgehog signaling in hepatocellular carcinoma: A pilot study." Dr. Federico N. Aucejo accepts all Medicare patients.
Publications
- Oncologic results of laparoscopic Liver resection for malignant Liver tumors.
- Risk stratification of alloGraft failure secondary to hepatitis C recurrence after liver transplantation.
- Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver Disease (NAFLD) patients without cirrhosis.
- Prognostic Role of Plasma Vascular Endothelial Growth Factor in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
- Neo-adjuvant therapy for hepatocellular carcinoma before Liver transplantation: where do we stand?
- Liver Transplantation for Malignancies.
- Initial experience with a new articulating energy device for laparoscopic Liver resection.
- Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after Liver transplantation.
- Laparoscopic versus open resection of Colorectal liver metastasis.
- Complementary Use of Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastases: An Analysis of 395 Patients.
- Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoRegional therapies.
- Duodenoportal fistula resulting from peptic ulcer after extended right hepatectomy for cholangiocarcinoma.
- Comparative analysis of the safety and efficacy of transcatheter Arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellul...
- Is impaired hepatic arterial buffer response a risk factor for Biliary anastomotic stricture in liver transplant recipients?
- Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during Liver transplantation.
- Expanding the donor pool: safe transplantation of a cadaveric liver alloGraft with a 10 cm cavernous hemangioma--a case report.
- Use of tissue plasminogen activator in Liver transplantation from donation after cardiac death donors.
- Total tumor volume predicts recurrence of hepatocellular carcinoma after Liver transplantation in patients beyond Milan or UCSF criteria.
- Rate of tumor growth predicts recurrence of hepatocellular carcinoma after Liver transplantation in patients beyond Milan or UCSF criteria.
- Adjuvant treatment after orthotopic Liver transplantation: is it really necessary?
- Measurement of CD4+ T-cell function in predicting alloGraft rejection and recurrent hepatitis C after liver transplantation.
- Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic Liver is higher when hepatoma is beyond Milan criteria.
- Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow Obstruction after liver transplanta...
- The significance of metabolic syndrome in the setting of recurrent hepatitis C after Liver transplantation.
- Split liver transplantation: Will it ever yield Grafts for two adults?
- "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not Arterial siphon.
- Cruveilhier-Baumgarten Disease in a patient with Turner syndrome: case report of a rare indication for liver transplantation.
- Recurrent hepatitis C after Liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
- Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic Liver transplantation.
- Robotic versus laparoscopic resection of Liver tumours.
- Techniques of radiofrequency-assisted precoagulation in laparoscopic Liver resection.
- Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic Liver transplantation.
- Safe use of sorafenib in a patient undergoing salvage Liver transplantation for recurrent hepatocellular carcinoma after hepatic resection.
- Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma?
- Hepatic blood flow plays an important role in ischemia-reperfusion injury.
- Duct-to-Duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation.
- Multimodality treatment of neuroendocrine Liver metastases.
- Liver transplantation at Cleveland Clinic.
- Splenic artery embolization for the treatment of refractory ascites after Liver transplantation.
- What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.
- Short segment aortic endarterectomy--a technique to aid cannulation in donors with severe aorto-iliac Disease.
- Insulin-like growth factor I receptor ? expression in hepatocellular carcinoma.
- Preservation solutions in Liver transplantation: what are the options?
- Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after Liver transplantation?
- Pulmonary hypertension after Liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature.
- Isolated right hepatic vein Obstruction after piggyback liver transplantation.
- General overview of neo-adjuvant therapy for hepatocellular carcinoma before Liver transplantation: necessity or option?
- Sonic hedgehog signaling in hepatocellular carcinoma: A pilot study.
Procedures Preformed
- Adrenalectomy
- Appendectomy, Open
- Biopsy of Breast
- Cystectomy
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Bile Duct Cancer
- Biliary Atresia
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Favaloro University Faculty of Medical Science
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1497822191 | |
| NPPES Provider LastName | AUCEJO | |
| NPPES Provider FirstName | FEDERICO | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | General Surgery | |
| Total Claim Count | 565.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497822191 |
| Last Name Of The Provider | AUCEJO |
| First Name Of The Provider | FEDERICO |
| View All |
Similar Doctors
|
Dr. Edward M. Barksdale Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce J. Averbook, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey M. Hardacre, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey L. Ponsky, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marjie L. Persons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramona N. Ilie, MD |
|
|
Dr. Neil W. Gibson, MD |
|
|
Dr. Arnab Majumder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles M. Wojnarski, MD
This Doctor is OpenDoctor Recommended.
|